9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Hilliard, Marisa E., Isaacs, Diana, Johnson, Eric L., Kahan, Scott, Khunti, Kamlesh, Leon, Jose, Lyons, Sarah K., Perry, Mary Lou, Prahalad, Priya, Pratley, Richard E., Seley, Jane Jeffrie, Stanton, Robert C., Gabbay, Robert A.·2023·Diabetes Care

DOI 10.2337/dc23-s009

Cited by (852)

Items 601–700 of 852

Prevalence of Vitamin B12 Deficiency in Patients With Type 2 Diabetes Mellitus on Metformin Therapy: A Cross-Sectional Study
Shoaib Asghar, Haider Tanvir, Asad Riaz, Muhammad Hamza Ejaz, Mamuna Akram, Al Muktadir Chowdhury Evan, Salman Shahid · 2024 · Cureus
Application of liquid chromatography-mass spectrometry for the determination of semaglutide in human serum in clinical pharmacokinetic studies
P. Karnakova, E. S. Vetrova, P. Karpova, A. Knyazeva, O. Archakova, N. Bagaeva, A. Arefeva, V. Banko, I. Makarenko, T. Komarov et al. · 2024 · Meditsinskiy sovet = Medical Council
Clinical insights from continuous glucose monitor use in patients living with type 1 diabetes in rural Malawi
Gina Ferrari, Medson Boti, Dester Nakotwa, A Gomber, MM Coates, Kenwood Kumwenda, Francis Valeta, Laura Drown, A Thapa, Victor Saidi Mithi et al. · 2024 · Journal of Endocrinology Metabolism and Diabetes of South Africa
Pharmacokinetic and Pharmacodynamic Equivalence of Biosimilar and Reference Ultra‐Rapid Lispro: A Comparative Clamp Study in Healthy Volunteers
Sergei Noskov, Ekaterina Koksharova, Anna Arefeva, V. V. Banko, К. S. Radaeva, Iuliia Matvienko, Maria Gefen, И. Е. Макаренко, Драй Роман Васильевич · 2025 · Clinical Pharmacology in Drug Development
Efficacy and Safety of Vildagliptin Sustained-Release and Metformin Sustained-Release Fixed-Dose Combination in Indian Patients With Type 2 Diabetes Mellitus: A Real-World Perspective
Archana Sarda, Bhavana Sosale, Balaji Jagan Mohan, Snehal Tanna, Vipul Gupta, Sanjay Gupta, Deepak Langade, Rahul Kotwal, Vivek Kolapkar, Kamlesh Patel · 2025 · Cureus
Changes in diabetes screening and exercise during the COVID-19 pandemic in adults with prediabetes
Luis A. Rodríguez, Maher Yassin, Obidiugwu Kenrik Duru, Romain S. Neugebauer, Susan D. Brown, Yelba Castellon‐Lopez, Tainayah Thomas, Julie A. Schmittdiel · 2025 · Diabetes Research and Clinical Practice
Racial and ethnic differences in prescribing antihyperglycemic medications to persons with type 2 diabetes: An all of us cohort study
Veronica J. Brady, Samuel Akyirem, Nikhil S. Padhye · 2025 · Primary care diabetes
Factors Associated with Response to SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Veterans with Type 2 Diabetes Mellitus
Gunjan Arora, Sulman Hashmi, Kaeli K. Samson, Sarah Khozema Hussain Azad, Jaskaran Batra, Vijaya deepika Perugu, Clifton Davis, Cyrus V Desouza · 2025 · Journal of Clinical Medicine
From In Vitro Efficacy to Long‐Term HbA1c Response for GLP‐1R/GlucagonR Agonism Using the 4GI‐HbA1c Systems Model
Rolien Bosch, Marcella Petrone, Rosalin Arends, Eric J.G. Sijbrands, Sven Hoefman, Nelleke Snelder · 2025 · CPT Pharmacometrics & Systems Pharmacology
Fixed-dose combinations of hypoglycemic drugs: potential of alogliptin/pioglitazone in type 2 diabetes mellitus: a review
Olga Igorevna Butranova, Sergey Kensarinovich Zyryanov, Anna R. Melnikova, Anastasia E. Matsepuro · 2025 · Terapevticheskii arkhiv
Cardiovascular benefits of liraglutide in patients with type 2 diabetes: an in-depth exploration
Amruth A Alluri, Avishek MITRA, Aamuktha Marepalli, Kshitij RAJ, Nayan Gandhi, Yuliya Prystupa, Rajmohan Seetharaman · 2025 · Minerva Cardiology and Angiology
Changes in prescription patterns of antidiabetic medication in patients newly diagnosed with type 2 diabetes in Spain: an observational study
Lucía Cea Soriano, Almudena Moreno-Lostao, Marta Calonge, Antonio Rivas, José Pulido, María Constanza Colchero, Sara Artola, Rosario Serrano, Josep Franch‐Nadal, Enrique Regidor · 2025 · BMJ Open
Semaglutide: a glucagon-like peptide-1 receptor agonist and its therapeutic potential in type 2 diabetes and beyond
Wenshan Zhao, Xiaoshuang Niu, Xiao‐Wen Zhou, Ranran Shi, Xiuman Zhou · 2025 · Elsevier eBooks
Pharmacokinetics and Safety of Fixed‐Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean Subjects
Young‐Sim Choi, JaeJin Na, Seo Yeong Park, Jae Min Cho, Yoonhye Jeong, Jun Gi Hwang · 2025 · Clinical and Translational Science
Therapeutic Potential of Acalypha wilkesiana in Type 2 Diabetes: A Review
Samuel Inshutiyimana, Patel Dineshbhai Yesh, Michael Matiop Aleu, Aibekhanya Nkosana Sebata, Kenfa Ajumesi, Norhayati Norhayati · 2025 · Journal of Diabetes Research
Comparison of three types of drugs for cardiovascular and renal benefits in type 2 diabetes mellitus
Xuedong An, Xueqin Li, He Zhang, Qian-You Jia, Yuehong Zhang, Gui-Gui Yang · 2025 · World Journal of Diabetes
Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus
Riccardo Candido, Raffaella Buzzetti, Agostino Consoli, Concetta Irace, Enrico Torre, Roberto Trevisan, Gian Paolo Fadini, T2D once-Weekly Insulin Expert Panel Group, Cesare Berra, Paolo Di Bartolo et al. · 2025 · Acta Diabetologica
Impact of PRKAA2 and LKB1 genetic variants on metabolic alterations in response to metformin–sulfonylurea therapy
Aliya Abbas Rizvi, Mohammad Abbas, Asma Imran Ansari, Sushma Verma, Zeba Siddiqi, Farzana Mahdi · 2025 · Biomarkers in Medicine
Limited Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Appetite and Body Weight: Evidence From Clinical and Rodent Studies
Joonyub Lee, Sohee Park, Evonne Kim, Ji-Yeon Park, Marie Rhee, Jing W. Hughes, Seung‐Hyun Ko, Obin Kwon, Eun Young Lee · 2025 · Journal of Korean Medical Science
Comparative effects of second-line oral antidiabetic medications on atrial fibrillation risk in patients with type 2 diabetes: a nationwide retrospective cohort study
Ga Young Heo, Seok‐Jae Heo, Byounghwi Ko, Ye Eun Ko, Hee Byung Koh, Cheol Ho Park, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Shin‐Wook Kang et al. · 2026 · Cardiovascular Diabetology
Estándares SEA 2026 para el control global del riesgo vascular
Jose Maria Mostaza, Xavier Pintó, Pedro Armario, Carlos Guijarro, L. Masana, José Tomás Real, Teresa Arrobas-Velilla, Ramón Baeza‐Trinidad, Pilar Calmarza, Jesús Cebollada et al. · 2026 · Clínica e Investigación en Arteriosclerosis
Zein/gelatin coaxial nanofibers for metformin encapsulation: assessment on composition, structure, and physicochemical properties
Rodríguez-Félix Francisco, Montaño-Grijalva Eneida Azaret, Enrique Márquez‐Ríos, Carmen Lizette Del‐Toro‐Sánchez, Rodríguez-Félix Dora Evelia, Ricardo Nalda‐Molina, José Agustín Tapia‐Hernández, Elizabeth Carvajal‐Millán, López-Peña Itzel Yanira, Carlos Gregorio Barreras‐Urbina et al. · 2026 · Polymer Bulletin
Efficacy and Safety of Once-Weekly IcoSema Versus Once-Daily IDegLira in People with Type 2 Diabetes: Systematic Literature Review and Network Meta-analysis
Saikrishna Kandalam, Malik Benamar, Corinne Le Reun, Lauren Rengger, Palvi Gupta, Sunita Nair · 2026 · Diabetes Therapy
Dietary Carbohydrate Modulation in Metabolic Syndrome: Mechanistic Insights, Gut Microbiota Interactions, and Precision Nutrition Approaches
Qiang Gao, Yong Li, Li Wang · 2026 · Food Reviews International
Deprescribing Following Access to Lifestyle Treatment: A Retrospective Chart Review of Primary Care Outcomes in Patients with Type 2 Diabetes
Yoav Jacob, Kara L. Staffier, Samveda Menon, Puja B. Gandhi, Joeita F. MacField, Gia Merlo, Stefanie M. Meyer, Shivani Patel, Caroline Rhéaume, Madeline Watson et al. · 2026 · Journal of Clinical Medicine
Glucose acts as a ligand for glucokinase to trigger postprandial secretion of GLP-1
Chun Li, Mengqi Li, Heng-Ye Yang, Xiao Tian, Chen‐Song Zhang, Lin Zhao, Jianfeng Wu, Cixiong Zhang, Shiqi Liu, Xiaotong Yang et al. · 2026 · Vita
Research on obesity using the National Health Information Database: recent trends
Eun‐Jung Rhee · 2023 · Cardiovascular Prevention and Pharmacotherapy
Time to Close the Gap Between Guidelines and the Reimbursement Policy for Diabetes Treatment in Turkey
Alper Tuna Güven · 2023 · PharmacoEconomics
Insulin Glargine Associated Nausea in a Patient Seen by a Collaborative Drug Therapy Management Pharmacist in an Urban Community Hospital: A Case Report
Anthony Gerber, Rachel E. Quinn · 2023 · Hospital Pharmacy
Pharmacotherapy of Type 2 Diabetes Mellitus
Pankaj Kumar Jha, Heta Shukla, Altaf Makwana, Ashutosh Kakkad · 2023 · IntechOpen eBooks
Prescription patterns in people who are frail
Isca Hershkowitz, Avivit Cahn · 2023 · The Lancet Healthy Longevity
A randomized, double‐blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy
Linong Ji, Jinmiao Lu, Leili Gao, Xiaoguang Yan, Jifang Li, Zhifeng Cheng, Lili Zhang, Junhang Tian, Ping Li, Jie Bai et al. · 2023 · Diabetes Obesity and Metabolism
Weekly insulin: a paradigm shift in type 1 diabetes therapy
AMY SANGHAVI SHAH, Risa M. Wolf · 2023 · The Lancet
Stufentherapie des Typ-2-Diabetes
Baptist Gallwitz · 2023 · MMW - Fortschritte der Medizin
Study Protocol for the Pleiotropic Effects of Sodium–Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 Diabetes
Yumie Takeshita, Chiaki Nomura, Hisayoshi Murai, Yusuke Mukai, Tadayuki Hirai, Takuto Hamaoka, Shota Tokuno, Takeo Tanaka, Hisanori Goto, Yujiro Nakano et al. · 2023 · Diabetes Therapy
An Overview of Insulin Therapy in the Management of Diabetes Mellitus
Marla J. Hayes · 2023 · Home Healthcare Now
Pathophysiology-Oriented Treatment of Type 2 Diabetes: 10 Case Reports
Noemi Nováková, Martin Nezval, Viktória Molnárová · 2023 · IntechOpen eBooks
Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study
Kentaro Watanabe, Susumu Yamaguchi, Yoshinori Kosakai, Tetsuya Ioji, Hisamitsu Ishihara · 2023 · Clinical Drug Investigation
Diabete e sindrome metabolica nel paziente con iperaldosteronismo primario
Stella Bernardi, Valerio Velardi, Federica De Luca, Giulia Zuolo, Veronica Calabrò, Riccardo Candido, Bruno Fabris · 2024 · L Endocrinologo
ADMIRE Study: Dapagliflozin and Metformin Fixed-dose Combination as Initial Choice of Therapy in Type 2 Diabetes Mellitus: A Real-world Study
Uday Phadke, Jayashree Gopal, Kaushik Biswas, Priyanka Joshi, Ashish Prasad, Ashish Birla · 2024 · Chronicle of Diabetes Research and Practice
Improvement of HbA1c, Weight and Fatty Liver by Short Treatment of Imeglimin (Twymeeg)
Takafumi Kawata, Hiroshi Bando, Yoshinobu Kato, Hisako Yamashita, Yoshikane Kato, Katsunori Ogura · 2024 · Asploro Journal of Biomedical and Clinical Case Reports
The Impact of Glycemic Control on Sodium-Glucose Co-Transporter 2 Inhibitor–Associated Genitourinary Infections
Anthony Gerber, Victoria Rupp, Natalia Ryabenkova, Nataliya Mikhelzon · 2024 · Annals of Pharmacotherapy
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan
Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi · 2024 · Diabetes Therapy
Age-related disease: Cardiovascular system
Peter M. Nilsson, Michael Fossel, Joe Bean, Nina Khera · 2024 · Elsevier eBooks
UM OLHAR SOBRE A ASSISTÊNCIA NA ATENÇÃO PRIMÁRIA À SAÚDE
Editora Inovar · 2024 · Editora Inovar eBooks
Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide
Caroline Swift, Monica Frazer, Noelle N. Gronroos, Andrew Sargent, Michael Leszko, Erin K. Buysman, Sara Alvarez, Tyler J. Dunn, Josh M. Noone, Mico Guevarra · 2024 · Diabetes Therapy
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Diabetes After 26 Weeks Treatment
Elena A. Christofides, Andrzej Stankiewicz, Douglas Scott Denham, Diego Bellido, Edward Franek, Samer Nakhle, Monika Łukaszewicz, John H. Chip Reed, María Victoria Cózar León, Christine Kosch et al. · 2024 · Endocrine Practice
Fixed-Dose Combination of Canagliflozin and Metformin as an Adjunct to Diet and Exercise in Indian Adults with Type 2 Diabetes Mellitus: Results from a Multicentric, Open-Label, Single-Arm, Phase IV Study
Mohan Magdum, AG Unnikrishnan, Faraz Farishta, Balamurugan R, Sreenivasa Murthy, Piyush Desai, Kiran Pal Singh, Manash Barauh, Ashu Rastogi, Jothydev Kesavadev et al. · 2024 · Journal of the Association of Physicians of India
Impact of Initial Treatment Policies on Long-term Complications and Costs in Japanese Patients with Type 2 Diabetes: A Real-World Database Study
Hiroshi Yoshihara, Tohru Tonoike, Hiromitsu Ohno, Susumu Nishiuchi, Ataru Igarashi · 2024 · Diabetes Therapy
Are patients with schizophrenia treated less with second-line glucose-lowering drugs for type 2 diabetes?
Søren Lundorff Jacobsen, Ole Köhler‐Forsberg, Christopher Rohde · 2024 · Schizophrenia Research
Pharmacokinetic Profile and Comparative Bioavailability of an Oral Fixed‐Dose Combination of Metformin and Acetylsalicylic Acid (Aspirin)
Lourdes Garza‐Ocañas, Christian Tadeo Badillo-Castañeda, Sandra Lucia Montoya-Eguía, María Teresa Zanatta-Calderón, Pedro Lennon Sáenz‐Chávez, Julia D. Torres‐Garza, Ileana C. Rodríguez-Vázquez, Yulia Romero‐Antonio, KEVIN F. RIOS-BRITO, Jorge González‐Canudas · 2024 · Clinical Pharmacology in Drug Development
Evaluation of remote pharmacist intervention on type 2 diabetes hemoglobin A1c reduction in an accountable care organization
Emily C. Nuttall, Timothy Reynolds, Ann Dao Kataria, Dwight Paulson, Jonathan Lewis, Angela C. Straza · 2024 · Baylor University Medical Center Proceedings
Is per capita fish consumption in Latin America aligned with international recommendations for a healthy diet?
Carla Guzmán, María José Andrade‐Cuvi, Juan Carlos Bórquez, Gabriel Araújo‐Silva, Angélica Quintero‐Flórez · 2024 · Food Science and Technology
Practical Applications of Russian DPP4 Inhibitor Gosogliptin in “Palitra” Large-Scale Observational Study
Marina Vladimirovna Shestakova, Elena Valer'evna Biryukova · 2024 · Diabetes Mellitus
Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study
Linong Ji, Leili Gao, Zhifeng Cheng, Guoqing Ma, Shu Li, Haifang Wang, Jie Liu, Yibing Lu, Mei‐Ying Liu, Jianlin Geng et al. · 2024 · Current Medical Research and Opinion
Assessment of clinician agreement with and knowledge of evidence‐based obesity treatment in the primary care setting
Angela R. Baalmann, Melissa C. Norton, Natalie R. Gadbois‐Mincks, Samuel Ofei‐Dodoo, Erica N. Presnell · 2024 · Obesity Science & Practice
N-glycan as new potential biomarker for predicting treatment response in patients with type 2 diabetes mellitus
Huijun Dong, Xiaohui Li, Qi-Xin Gu, Chifa Ma, Mingxia Yuan, Zhen-Zi Wang, Jianrong Su, Lei Xu, Cuiying Chen, Qiqige Ebule et al. · 2024 · Biomarkers in Medicine
Efficacy, safety and treatment satisfaction of transition to a regimen of insulin degludec/aspart: A pilot study
Na Yang, Lu Lv, Shu-Meng Han, Liyun He, Ziyi Li, Yu-Cheng Yang, Ping Fan, Lingling Xu, Wei Li, Huabing Zhang et al. · 2024 · World Journal of Diabetes
Once-Weekly Tirzepatide Versus Once-Daily Basal Insulin in Managing Type 2 Diabetes Inadequately Controlled With Oral anti-Hyperglycemic Drugs: A Systematic Review and Meta-Analysis
Abul B. M. Kamrul-Hasan, Shahjada Selim, Faria Afsana, Lakshmi Nagendra, Rezwana Ahmed, Deep Dutta · 2024 · Endocrine Practice
Glucagon-like peptide 1 receptor agonists outperform basal insulin in cardiovascular and renal outcomes for type 2 diabetes mellitus: a retrospective cohort study
Tien‐Hsing Chen, Chin-Ju Tseng, Yanrong Li, Yuan Lin, Dong‐Yi Chen, Ning‐I Yang, Te-Hsiung Wang, Ming‐Jui Hung, Ming‐Lung Tsai · 2025 · Acta Diabetologica
Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing
Sonia Roldan Munoz, Peter G. M. Mol, Femke de Vries, Peter Ruben van Dijk, Hans L. Hillege, Douwe Postmus, Sieta T. de Vries · 2025 · Patient Preference and Adherence
Metformin treatment for patients with hand osteoarthritis: protocol for the multicentre, randomised, placebo-controlled METRO trial
Kasper Staberg Madsen, Marius Henriksen, Anna Døssing, Asbjørn Seenithamby Poulsen, Rasmus Oscar, Tue Wenzel Kragstrup, Karen Ellegaard, Filip Krag Knop, Mikael Boesen, David John Hunter et al. · 2025 · BMJ Open
Advancing toward a curative frontier: an updated narrative review on stem-cell therapy in pediatric type 1 diabetes
Samia Aziz Sulaiman, Abdallah Alaarag, Nadin Rayyan, Yousof Tuffaha, Nada A. Al‐Awamleh, Khalid Adel Al Dojan · 2025 · World Journal of Pediatrics
Cost-utility of IDegLira versus alternative basal insulin intensification therapies in patients with type 2 diabetes mellitus uncontrolled on basal insulin in a Chinese setting
Junling Weng, Dunming Xiao, Yingyao Chen · 2025 · Diabetology & Metabolic Syndrome
Do Provincial Formulary Restrictions Explain Differential Uptake of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Diabetes and Cardiovascular Disease in Canada? A Retrospective Cohort Study of Pharmacy Claims
Darren Lau, Douglas C. Dover, Hena Qureshi, Roseanne O. Yeung, Dean T. Eurich, Peter Alexander Senior, Sonia Butalia, Padma Kaul · 2025 · Canadian Journal of Diabetes
Advancements and challenges in the management of obesity using pharmacotherapy (Review)
Saqer S. Alotaibi, Essam Hassan Eldrehmy, Sarah M. Albogami, Adel Qlayel Alkhedaide, Omima Dahab · 2025 · Experimental and Therapeutic Medicine
Variation in uptake of sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor analogues in adults with type 2 diabetes at high cardiovascular risk
Juliana de Oliveira Costa, Jialing Lin, Tamara Y. Milder, Alys Havard, Jerry Richard Greenfield, Richard Osborne Day, Brendon Lange Neuen, Alice Anne Gibson, Jedidiah I Morton, Julian W. Sacre et al. · 2025 · European Journal of Clinical Pharmacology
Case Report: Clinical pharmacist prescriber in depression treatment in primary care settings: clinical case focused on prescribing practice
Matej Štuhec · 2025 · Frontiers in Psychiatry
Insulin Dosing Safety in CKD
Alexis M. McKee, Kai E. Jones, Janet B. McGill · 2023 · Kidney International Reports
Recommandations rapides
Danielle O’Toole · 2023 · Canadian Family Physician
Rapid recommendations
Danielle O’Toole · 2023 · Canadian Family Physician
Using dapagliflozin in patients with heart failure
LaKeisha G. Williams, Tori Wiley · 2023 · Nursing
A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?
Basem M. Mishriky, Doyle M. Cummings, James R. Powell · 2023 · Diabetes/Metabolism Research and Reviews
Optimal Low-Density Lipoprotein Cholesterol Level for Primary Prevention in Koreans with Type 2 Diabetes Mellitus
Ji Yoon Kim, Nam Hoon Kim · 2023 · Diabetes & Metabolism Journal
Cardiovascular Risk Reduction in Type 2 Diabetes: Further Insights into the Power of Weight Loss and Exercise
Seung‐Hwan Lee · 2023 · Endocrinology and Metabolism
Metformin to Prevent Anthracycline Cardiotoxicity?
Malak El-Rayes, Michelle B. Nadler, Husam Mohamed Abdel-Qadir · 2023 · JACC CardioOncology
The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation
Yongin Cho, Sung‐Hee Shin, Min-Ae Park, Young Ju Suh, Sojeong Park, Ji-Hun Jang, Dae-Young Kim, So Hun Kim · 2023 · medRxiv
Impact of the COVID-19 pandemic on antidiabetic drugs initiation in Sweden, an interrupted time series study
Nataliia Khanyk, Fredrik Nyberg, Björn Wettermark, Huiqi Li, Katarina Eeg‐Olofsson, Soffia Guðbjörnsdóttir, Mohammadhossein Hajiebrahimi · 2024 · medRxiv
Heterogeneous Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Acute Kidney Injury: A Causal Learning Approach
Hao Dai, Yao An Lee, Jiang Bian, Jingchuan Serena Guo · 2025 · medRxiv
Machine learning-driven risk prediction for post-hospitalization diabetes case management: Integrating clinical and social determinants of health
Lee, Seung-Yup, Saleem, Mohammad, Land, Andrew M., DeLaney, Erin W., Garretson, Alison R., Patel, Mahee, Hall, Allyson G., Westrick, Salisa, Ovalle, Fernando, Cherrington, Andrea L. et al. · 2026 · International Journal of Medical Informatics
Activité physique dans le diabète de type 2
Martine Duclos · 2026 · EMC - Traité de médecine AKOS
Effect of tirzepatide on prediabetics and blood pressure with implications for future research
Rajmohan Seetharaman · 2023 · Journal of Basic and Clinical Physiology and Pharmacology
Author Response to “Insulin Dosing Safety in CKD”
Radica Z. Alicic, Joshua J. Neumiller, Rodolfo Javier Galindo, Katherine R. Tuttle · 2023 · Kidney International Reports
Detail Measurement of Pre-Prandial and Post-Prandial Blood Glucose during Imeglimin (Twymeeg) Treatment
Kenji Hayashi, Hiroshi Bando, Kazuya Miki, Misaki Hamai, Tatsuo Yasuoka · 2023 · Asploro Journal of Biomedical and Clinical Case Reports
Absolute Benefits From Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors
Michael P. Bancks · 2023 · Diabetes Care
Identification of Glucagon Secretion Patterns during an Oral Glucose Tolerance Test
Andrew Shahidehpour, Mudassir Mohammad Rashid, Mohammad Reza Askari, Mohammad Ahmadasas, Ali Çınar · 2023 · Endocrines
Does GLP-RA Plus an SGLT2 Inhibitor Yield Greater Weight Loss in Patients with Obesity and Diabetes than Monotherapy?
Caraline Watkins, Zoe Schilling, Kevin Kawalec, Darrell T. Hulisz · 2023 · Current Cardiovascular Risk Reports
Advice and challenges in the pharmacotherapeutic management of diabetic kidney disease in adults
Clemens Plattner, Markus Pirklbauer, Gert J. Mayer · 2023 · Expert Opinion on Pharmacotherapy
Glycaemic control and weight outcomes after adding or switching to biphasic insulin aspart 30/70 in people with type 2 diabetes mellitus previously treated with basal–bolus insulin in UK clinical practice
Melanie Jane Davies, Amra Ciric Alibegovic, Pranav Kelkar, Uffe Christian Braae, Anders Boeck Jensen · 2023 · Diabetes Obesity and Metabolism
Inflammation and Diabetes Mellitus
Sooyoung Lim, Sudipa Sarkar, Rexford S. Ahima · 2023 · Contemporary Endocrinology
Diabesity Treatments Today and Tomorrow
George Pavlakis, Jennifer D. Goldman · 2023 · ADCES in Practice
Redefining Diabetes Strategies in Primary Care: Four New Pillars of Management
Akshay Jain · 2023 · Canadian Primary Care Today
Encouraging but slow progress toward incorporating obesity care into diabetes care
Jaime P. Almandoz, Ildiko Lingvay · 2023 · Obesity
TYPE 2 DIABETES AND BONE HEALTH: an epidemiological approach
Rikke Viggers · 2023
Glucagon-related advancements in diabetes therapy
Binayak Sinha, Samit Ghosal, Satinath Mukhopadhyay, Akhtar Hussain, Anjana Ranjit Mohan, Peter E. H. Schwarz, Xavier Cos · 2023 · Journal of Diabetology
An exanthematous drug eruption with sodium‐glucose cotransporter 2 inhibitor
Ryu Fukase, Souta Saito, Hideto Yoshida · 2023 · Journal of General and Family Medicine
A 33-Year-Old Man Presented with Abdominal Pain and Vomiting Starting a Day Ago
Jong Han Choi · 2023 · Korean Journal of Medicine
Effect of Liraglutide on Weight Loss and BMI Among Patients Who Are Overweight and Obese with Type 2 Diabetes: A Systematic Review and Meta-analysis
C. Zorampari, Rachna Gupta, Lalit K Gupta · 2023 · European Medical Journal
El papel de la insulina en el tratamiento actual de la persona con diabetes mellitus tipo 2
Gustavo Mora Navarro, Myriam Menéndez Ortega, Nonfa Castillo Biscari · 2023 · Diabetes práctica
Extremely high-dose insulin requirement in a diabetic patient with psychiatric illness: A case report
Kibret Enyew Belay, Beza Leulseged Ayalew, Abdissa Meherete Etana, Mohammadjavad Ashrafi Mahabadi · 2023 · SAGE Open Medical Case Reports